EUVIMEDEUVIMED entdecken
Crossref

Molecular Docking Study of Annona muricata Bioactive Compounds Against Caspase 3

Raimot Ojedokun, Qawiyy Ogunrinola, Adebayo Olugbode

Archives of Advances in Biosciences · 01.09.2025

DOI: 10.22037/aab.v16i1.50084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Advances in Biosciences, erschienen am 01.09.2025. Verfasst von Raimot Ojedokun und 2 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Soursop, or Annona muricata, is a plant that has long been used to treat a variety of illnesses, including cancer. The purpose of this study was to use an in-silico method to assess the anti-cancer activity of chemicals produced from Annona muricata. Materials and Methods: To determine the bioactive substances found in Annona muricata that are known to have anti-cancer qualities, a thorough literature research was carried out. Following that, these substances were put through molecular docking tests against important protein targets linked to cancer, including receptors implicated in angiogenesis, apoptosis, and cell proliferation. Possible interactions between the identified Annona muricata chemicals and cancer-associated protein targets were discovered by the in-silico research.

Results

Several compounds demonstrated favorable binding interactions with Caspase-3. Coreximine showed the most favorable docking score (−6.7 kcal/mol), followed by Catechin (−6.5 kcal/mol), making these two the strongest potential bioactive or therapeutic candidates, Anomurine (−5.8 kcal/mol), Solamin (−5.4 kcal/mol), Annonacin (−4.8 kcal/mol), and Gallic acid (−4.7 kcal/mol). In contrast, the reference compound Doxorubicin displayed a weaker score (−2.2 kcal/mol). These docking values suggest potential micromolar-range affinities for several A. muricata compounds, which, while encouraging, indicate that they are likely to serve as lead compounds rather than direct therapeutic agents. The docking results highlighted promising candidates, although weaker docking indicates natural compounds’ potential advantage; however, real-world efficacy depends on multiple pharmacological factors and their biological and clinical significance can only be established through further experimental studies, including enzyme inhibition assays, cell-based apoptosis assay and in vivo validation.

Conclusion

In summary, this in-silico work opens the door for the creation of innovative natural anti-cancer treatment medicines by offering important insights into the molecular mechanisms behind Annona muricata's anti-cancer action.

Schlagwörter

Annona muricatacaspase-3 inhibitionanticancer activitycatechinsannonacingallic acidbioactive natural productsmolecular dockingapoptosisangiogenesis

Zitieren

APA

Ojedokun, R., Ogunrinola, Q., & Olugbode, A. (2025). Molecular Docking Study of Annona muricata Bioactive Compounds Against Caspase 3. Archives of Advances in Biosciences. https://doi.org/10.22037/aab.v16i1.50084

Vancouver

Ojedokun R, Ogunrinola Q, Olugbode A. Molecular Docking Study of Annona muricata Bioactive Compounds Against Caspase 3. Archives of Advances in Biosciences. 2025. doi:10.22037/aab.v16i1.50084

BibTeX
@article{Ojedokun2025,
  author = {Ojedokun, Raimot and Ogunrinola, Qawiyy and Olugbode, Adebayo},
  title = {Molecular Docking Study of Annona muricata Bioactive Compounds Against Caspase 3},
  journal = {Archives of Advances in Biosciences},
  year = {2025},
  doi = {10.22037/aab.v16i1.50084}
}
Kostenlos starten →